Close Menu

cervical cancer

NEW YORK (GenomeWeb News) – Once the $3.7 billion Hologic acquisition of Gen-Probe is completed, Gen-Probe will become the "hub" of Hologic's diagnostics business, and in addition to selling the San Diego company's

BRL launches InCellDx's HPV mRNA Test
Bio-Reference Laboratories announced this week that its GenPath Women's Health division has launched a new test called GenCerv.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Qiagen and Roche today welcomed new guidelines recommending the use of molecular testing for human papillomavirus screening in conjunction with Pap smears.

This story has been updated from a previous version to clarify comments regarding the Aptima HPV test specificity.
By Ben Butkus

The device, named the Verisante Aura, uses Raman spectroscopy to measure levels of various biomarkers – including proteins, nucleic acids, and metabolites – in skin lesions. In initial clinical trials it distinguished between benign and malignant lesions with 100-percent sensitivity and 70-percent specificity.

The assay may provide insight into the relationships between various HPV types and their associated diseases — not just cervical cancer, but also potentially head and neck cancers and HPV-associated warts.

Roche presents data from HPV Dx trial; Epigenomics launches Epi proLung BL Reflex Assay in Europe.

Incell's HPV test will be run on Accuri's cytometer as a cervical cancer screening tool.

Enzo Clinical Labs will market the cervical cancer test in New York and New Jersey.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.